For years, parents who questioned whether puberty blockers were safe for their children were met with a single statistic: a 72 percent increase in suicide attempts among transgender youth who weren't allowed to transition. Question the treatments, they were told, and children die. It was the conversation-stopper that ended debates in school board meetings, state legislatures, and pediatricians' offices across the country.
The study behind that statistic has been debunked. And the federal government now says the organization that used it to shut down questions was engaged in consumer fraud.
The Federal Trade Commission, joined by four states and led by Chairman Andrew N. Ferguson, filed suit against the World Professional Association for Transgender Health — better known as WPATH — for making deceptive claims about transgender medical treatments pushed on children. The organization that defined the standard of care for gender medicine, whose guidelines shaped policy in dozens of states, is now a defendant in a federal fraud case.
Ferguson's statement was precise. "Children, but especially their parents, must have complete and truthful information when making decisions to purchase medical services," he said. "When an entity makes a claim about a medical treatment, the claim must be truthful, evidence-based and not misleading."
Truthful. Evidence-based. Not misleading. Three things WPATH apparently couldn't manage while telling scared parents that puberty blockers were perfectly fine.
Texas Attorney General Ken Paxton, who joined the suit, was more direct: promoting "irreversible, life-altering 'transitioning' procedures" to children as safe is illegal, and those responsible will "face the full force of the law."
The 72 percent suicide statistic — published in Nature Human Behavior — was the load-bearing claim of the entire movement. It was cited in court cases, legislative hearings, and news segments as the reason any hesitation about pediatric gender medicine was dangerous. When researchers identified fundamental flaws in the study's methodology, the response from gender medicine advocates wasn't correction. It was silence, followed by continued citation. As Townhall's Julia Cassidy reported, the FTC has specifically targeted this claim in the lawsuit.
The side effects WPATH failed to disclose to parents include mood disturbances, vocal pain, pelvic pain, clitoral discomfort, vaginal pain, inability to orgasm, incontinence, and erectile pain. These are documented outcomes — the same ones any legitimate informed consent process would require parents to understand before agreeing to treatment for their children. WPATH, the organization that held the keys to what constituted legitimate gender care, left them out.
They suppressed the side effects. They promoted a debunked study as scientific consensus. They called the result evidence-based medicine. The FTC has a word for that.
Every hospital system, medical institution, and state agency that based its policies on WPATH's guidelines did so trusting that the underlying evidence was real. The lawsuit doesn't just target one organization — it calls into question the entire credentialed apparatus that told American parents their concerns were bigotry and their instincts were dangerous. What gets litigated in this case isn't just WPATH's conduct. It's the claim that anyone who asked questions was the problem.
Every parent who was called a bigot for protecting their child deserves to see this lawsuit through to the end.
